These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5030597)

  • 1. [Chemical determination of rifampicin in the urine].
    Wareska W
    Gruzlica; 1972 May; 40(5):419-24. PubMed ID: 5030597
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methods of determination of rifampicin in the urine].
    Ioffe RA
    Antibiotiki; 1973 Sep; 18(9):799-802. PubMed ID: 4761951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic usefulness of a chemical method of determination of rifampicin in urine].
    Janiszewski M; Szewczyk I
    Gruzlica; 1975 Feb; 43(2):157-62. PubMed ID: 1112531
    [No Abstract]   [Full Text] [Related]  

  • 4. Microbiological assay versus spectrophotometry for determination of rifampicin in urine.
    George J; Bhatia VN; Balakrishnan S
    Indian J Lepr; 1988 Jan; 60(1):47-52. PubMed ID: 3060546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Method for determination of rifampicin in urine].
    Georgescu P; Muşeţeanu R; Zaharescu C
    Ftiziologia; 1971; 20(1):93-6. PubMed ID: 5162269
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary excretion of rifampicin and its metabolites as an index of rifampicin blood levels.
    Wardell WM; McQueen EG
    N Z Med J; 1970 Dec; 72(463):393-6. PubMed ID: 5278257
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of a chloramphenicol-rifampicin combination in rats].
    Cantelli Forti G; Fracasso ME
    Boll Soc Ital Biol Sper; 1971 Oct; 47(19):575-7. PubMed ID: 5140771
    [No Abstract]   [Full Text] [Related]  

  • 8. The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
    Pillai G; Ellard GA; Smith PJ; Fourie PB
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):691-5. PubMed ID: 11495257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT; Vakhmistrova TI; Perova TL
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Developement of serum and urine concentrations of rifampicin during treatment].
    Pechère JC; Tancrède C
    Pathol Biol (Paris); 1969 Feb; 17(3):155-8. PubMed ID: 4892933
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations.
    Acocella G; Segre G
    Acta Pharm Suec; 1974 Dec; 11(6):657-8. PubMed ID: 1136808
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative determinations of levofloxacin and rifampicin in pharmaceutical and urine samples using nuclear magnetic resonance spectroscopy.
    Salem AA; Mossa HA; Barsoum BN
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Nov; 62(1-3):466-72. PubMed ID: 16257748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and saliva concentrations of rifampicin in man after oral administration.
    Orisakwe OE; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):45-9. PubMed ID: 9239804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
    Balakrishnan ; Seshadri PS
    Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of rifampicin in urine causes cross-reactivity with opiates using the KIMS method.
    Herrera Trevilla P; Ortiz Jimenez E; Tena T; Lora Tamayo C
    J Anal Toxicol; 1995; 19(3):200. PubMed ID: 7564301
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.
    Meissner PE; Musoke P; Okwera A; Bunn JE; Coulter JB
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):903-8. PubMed ID: 12365577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism of rifampicin in the human body (1st report)].
    Nakagawa H; Sunahara S
    Kekkaku; 1973 May; 48(5):167-76. PubMed ID: 4732656
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.
    Furesz S; Scotti R; Pallanza R; Mapelli E
    Arzneimittelforschung; 1967 May; 17(5):534-7. PubMed ID: 5631581
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
    Gurumurthy P; Ramachandran G; Vijayalakshmi S; Kumar AK; Venkatesan P; Chandrasekaran V; Vjayasekaran V; Kumaraswami V; Prabhakar R
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):119-25. PubMed ID: 10091876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.